The Phase I/II Oasis trial is asssing the safety and efficacy of OsteoAdapt SP, an implant made from synthetic material, according to a Nov. 19 news release shared with Becker’s. The implant also has a uniquely designed protein to encourage bone growth.
David Schwartz, MD, performed the first procedure in the clinical trial, and M. Craig McMains, MD, completed the second case.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.